GMP News - Quality Assurance

14.08.12

FDA issued 8 Warning Letters to Companies because of Missing Establishment Registration

Within 5 months, the FDA has issued 8 Warning Letters to companies who failed to comply with the obligation to register production establishments. Read more here.

more

11.07.12

FDA - S6 Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals

The US Food & Drug Administration (FDA) published two Guidances for Industry with regard to Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals. Find more details here.

more

04.07.12

MHRA publishes GMP Deficiency Data Review April 2011 - March 2012

In April, the Medicines and Healthcare products Regulatory Agency (MHRA), UK, issued a review of the main GMP deficiencies for the period from April 2011 to March 2012. More details can be found here.

more

13.06.12

News PIC/S Structure

In its latest press release, the Pharmaceutical Inspection Co-operation Scheme PIC/S highlighted the outcome of its last Committee Meeting. What are the main news? Read more.

more

13.06.12

FDA starts Voluntary Audit Report Program for Medical Devices

On 5 June 2012, the FDA has begun a "voluntary program" for medical devices audits entitled "Medical Devices ISO 13485:2003 Voluntary Audit Report Submission Pilot Program" - based on ISO 13485:2003. The purpose is to extend FDA's inspection intervals. Read more.

more

06.06.12

Half-year Report 2012: FDA Medical Devices Warning Letter Statistics

We regularly analyse the Warning Letters issued by the FDA. The following information presents the current evolution of the Top 5 hit list - with regard to medical devices - for the first half of the fiscal year 2012 (from 1st October 2011 to 15 March 2012). Read more.

more

06.06.12

EMA: Practical Guidance on Implementation of Pharmacovigilance Legislation published

The European Medicines Agency has published a set of questions and answers concerning the initial phases of the operation of the new pharmacovigilance legislation. Read more.

more

05.06.12

FDA's new Guidance Documents for 2012

The  U.S. Food and Drug Administration FDA has issued its yearly list of planned draft and final guidance documents for 2012. There are about 50 such guidance documents planned. Read more.

more

16.05.12

Foundation of a new French Health Regulation Authority

The existing French health authority has been re-organised. The AFSSAPS has been replaced by the ANSM (Agence nationale de sécurité du médicament et des produits de santé). Read on.

more

09.05.12

FDA Update

The FDA has published a presentation on ongoing activities of the FDA. Read more.

more

11.04.12

FDA: Ensuring the Safety of Vaccines in the United States

The FDA published two documents on vaccines safety and the reporting of vaccine adverse events in the United States. More details can be found here.

more

14.03.12

PIC/S asks Inspectors to have a look at Job Cuts

In a new Recommendation on for Risk-Based Inspection Planning in the GMP Environment, the PIC/S asks Inspectors to have a look at job cuts. Read more.

more

07.03.12

EMA Reflection Paper on Sourcing Biological Starting Materials

According a new Reflection Paper, the European Medicines Agency (EMA) wants companies to trace their heparin supplies back to the slaughterhouse. Read more.

more

07.03.12

New Chinese GMP rules published in English

The Chinese Ministry of Health has published revised GMP rules for drugs in the beginning of 2011. March 1, 2011 was specified as date for the entry into force. Now, an English translation is available. Read more about the main differences between the Chinese GMP rules and EU GMP Guideline Part I.

more

29.02.12

FDA Draft Guidance: How to qualify Heparin Suppliers

The U.S. Food and Drug Administration (FDA) recently published a draft Guidance on Monitoring Crude Heparin for Quality. Read more.

more

GMP Newsletter

Sign up for the free of charge newsletters.

Sign up now!

GMP Conferences by Topics